Thioredoxin as a biomarker for oxidative stress in patients with rheumatoid arthritis

Molecular Immunology

Volumn 38, Issue 10, 2002, Pages 765-772

  Jikimoto, Takumi ^a   Nishikubo, Yuko ^a   Koshiba, Masahiro ^a   Kanagawa, Sugayo ^a   Morinobu, Sahoko ^a   Morinobu, Akio ^a   Saura, Ryuichi ^a   Mizuno, Kosaku ^a   Kondo, Shohei ^b   Toyokuni, Shinya ^b   Nakamura, Hajime ^b   Yodoi, Junji ^b   Kumagai, Shunichi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

8 Hydroxy 2 deoxyguanosine (8 OHdG); Adult T cell leukemia derived factor (ADF); Oxidative stress; Rheumatoid arthritis; Thioredoxin (TRX)

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; OXYGEN RADICAL; THIOREDOXIN;

ADULT; AGED; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DNA DAMAGE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LEUKOCYTE; MALE; OSTEOARTHRITIS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID LEVEL; URINARY EXCRETION;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; THIOREDOXIN; UP-REGULATION;

EID: 18244381844     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(01)00113-4     Document Type: Article

References (41)

1. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
2. Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells
3. Structural basis for recognition and repair of the endogenous mutagen 8-oxoguanine in DNA
4. Effects of adult T-cell leukemia-derived factor on ultraviolet radiation-induced skin injury
5. Biomarker evidence of DNA oxidation in lung cancer patients: Association of urinary 8-hydroxy-2′-deoxyguanosine excretion with radiotherapy, chemotherapy, and response to treatment
6. Increased concentrations of nitrate in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases
7. Role of cytokines in rheumatoid arthritis
8. Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors?
9. Bleomycin-detectable iron in knee-joint synovial fluid from arthritic patients and its relationship to the extracellular antioxidant activities of caeruloplasmin, transferrin, and lactoferrin
10. Oxygen radicals, nitric oxide and human inflammatory joint disease
11. Rheumatoid arthritis: Pathophysiology and implications for therapy
12. Serum antioxidants and risk of rheumatoid arthritis
13. Thioredoxin
14. Sensitive enzyme-linked immunosorbent assay for adult T-cell leukemia-derived factor and normal value measurement
15. Intracellular and extracellular sulphydryl levels in rheumatoid arthritis
16. Analysis of the p53 tumor suppressor gene in rheumatoid arthritis synovial fobroblasts
17. A method for summation of the systemic indices of rheumatoid activity
18. Oxidative DNA-damage estimated by 8-hydroxydeoxyguanosine excretion in man: Influence of smoking, gender asn body mass index
19. Hypoxia, oxidative stress and rheumatoid arthritis
20. Evidence for a role of an altered redox state in hyporesponsiveness of synovial T cells in rheumatoid arthritis
21. Expression of the thioredoxin-thioredoxin reductase system in the inflamed joints of patients with rheumatoid arthritis
22. Suppression of arthritis by an inhibitor of nitric oxide synthase
23. Elevated levels of xanthine oxidase in serum of patients with inflammatory and autoimmune rheumatic diseases
24. Increased pentosidine, an advanced glycation end product, in plasma and synovial fluid from patients with rheumatoid arthritis and its relation with inflammatory markers
25. Glutathione reductase activity, riboflavin status, and disease activity in rheumatoid arthritis
26. Elevation of plasma thioredoxin levels in HIV-infected individuals
27. Redox regulation of cellular activation
28. Mesurement of plasma glutaredoxin and thioredoxin in healthy volunteers and during open-heart surgery
29. Apoptosis in rheumatoid arthritis
30. Urinary 8-hydroxy-2′-deoxyguanosine (8-OHdG) as a marker of oxidative stress in rheumatoid arthritis and aging: Effect of progressive resistance training
31. Pretranslational modulation of acute phase hepatic protein synthesis by murine recombinant interleukin 1 (IL-1) and purified human IL-1
32. Induction of ADF/TRX by oxidative stress in keratinocytes and lymphoid cells
33. Thioredoxin as a potent costimulus of cytokine expression
34. Thiol-mediated redox regulation of apoptosis. Possible roles of cellular thiols other than glutathione in T cell apoptosis
35. ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous of thioredoxin; possible involvement of dithiol-reduction in the IL-2 receptor induction
36. Rheumatoid arthritis and p53: How oxidative stress might alter the course of inflammatory diseases
37. A novel promotor sequence is involved in the oxidative stress-induced expression of the adult T-cell leukemia-derived factor (ADF)/human thioredoxin (TRX) gene
38. Reactive oxygen species-induced molecular damage and its application in pathology
39. Adult T-cell leukemia-derived factor-thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2
40. Free radicals in inflammation: Second messengers and mediators of tissue destruction
41. Involvement of thioredoxin in rheumatoid arthritis: Its costimulatory roles in the TNFα-induced production of IL-6 and IL-8 from cultured synovial fobroblasts